• Issue

    iLABMED: Volume 1, Issue 2

    i-iv, 93-141
    September 2023

ISSUE INFORMATION

Open Access

Issue Information

  • Pages: i-iv
  • First Published: 24 September 2023

COMMENTARY

Open Access

The incidence of liver abnormalities is higher in inactive hepatitis B virus carriers with influenza A infection

  • Pages: 93-98
  • First Published: 10 July 2023
The incidence of liver abnormalities is higher in inactive hepatitis B virus carriers with influenza A infection

Influenza A infection leads to a higher incidence of liver injury in HBV carriers than in patients infected with influenza A alone. Moreover, HBV carriers experience earlier onset and greater severity of liver injury than individuals with only influenza A.

REVIEW

Open Access

Application of autoantibody detection in chronic liver disease

  • Pages: 103-108
  • First Published: 14 June 2023
Application of autoantibody detection in chronic liver disease

Autoantibodies may appear characteristically in autoimmune liver disease, and some autoantibodies have become specific biomarkers. However, autoantibodies can also be detected in non-autoimmune liver diseases, such as viral liver disease and alcoholic liver disease with unclear distribution characteristics.

Open Access

The mechanism of copper homeostasis and its role in disease

  • Pages: 109-120
  • First Published: 08 August 2023
The mechanism of copper homeostasis and its role in disease

Copper is an essential trace metal indispensable for the function of numerous enzymatic molecules implicated in cellular metabolism. The authors review the process of copper metabolism, explore the underlying mechanisms of cuprotosis, and provide novel ideas for diagnosing and treating disorders of copper metabolism associated with copper toxicity.

ORIGINAL ARTICLE

Open Access

An iASPP-derived short peptide restores p53-mediated cell death in cancers with wild-type p53

  • Pages: 121-131
  • First Published: 11 July 2023
An iASPP-derived short peptide restores p53-mediated cell death in cancers with wild-type p53

We constructed an iASPP-derived short peptide A8, which can specifically combine with iASPP and reactivate the functional activity of p53, especially in apoptosis. Additionally, A8 restored the transcriptional function and DNA binding activities of p53 toward the Bax and PUMA gene promoters to finally inhibit tumor growth. Notably, our work presents a new candidate strategy to restore the tumor suppressive function of p53 in cancer cells.

Open Access

Clinical utility of six serum tumor markers for the diagnosis of lung cancer

  • Pages: 132-141
  • First Published: 12 September 2023
Clinical utility of six serum tumor markers for the diagnosis of lung cancer

This article investigated the clinical utility of the six serum tumor markers in differentiating between lung cancer and benign lung diseases through the comparative analysis of patient samples, and proved that combining the detection of ProGRP, NSE, CYFRA21-1, CEA, and SCCA significantly improves sensitivity when diagnosing lung cancer.